Cargando…

Outcomes of the Pediatric Development Plan of Tapentadol

The opioid analgesic tapentadol was the first pain medication to be developed for the treatment of pain in children under a formal process established by the regulatory authorities. This article summarizes the outcomes of the pediatric development program for tapentadol across the entire age range f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Eerdekens, Mariëlle, Radic, Tatjana, Sohns, Melanie, Khalil, Feras, Bulawa, Beata, Elling, Christian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7853428/ https://www.ncbi.nlm.nih.gov/pubmed/33542654 http://dx.doi.org/10.2147/JPR.S290487

Ejemplares similares

Tapentadol Prolonged Release for Long-Term Treatment of Pain in Children
por: Howard, Richard F, et al.
Publicado: (2020)

Multiple Dose Pharmacokinetics of Tapentadol Oral Solution for the Treatment of Moderate to Severe Acute Pain in Children Aged 2 to <7 Years
por: Jończyk, Renata, et al.
Publicado: (2022)

Population Pharmacokinetics of Tapentadol in Children from Birth to <18 Years Old
por: Khalil, Feras, et al.
Publicado: (2020)

Review of Post-Marketing Safety Data on Tapentadol, a Centrally Acting Analgesic
por: Stollenwerk, Ariane, et al.
Publicado: (2017)

Population pharmacokinetic modeling to facilitate dose selection of tapentadol in the pediatric population
por: Watson, Estelle, et al.
Publicado: (2019)

Tapentadol Prolonged Release for Severe Chronic Osteoarthritis Pain in the Elderly—A Subgroup Analysis of Routine Clinical Practice Data
por: Schwittay, Andreas, et al.
Publicado: (2020)

Tapentadol for the Treatment of Moderate-to-Severe Acute Pain in Children Under the Age of Two Years
por: Eissa, Ayman, et al.
Publicado: (2021)

Pharmacokinetics, safety, and efficacy of tapentadol oral solution for treating moderate to severe pain in pediatric patients
por: Muse, Derek, et al.
Publicado: (2019)

Does ‘Strong Analgesic’ Equal ‘Strong Opioid’? Tapentadol and the Concept of ‘µ-Load’
por: Raffa, Robert B., et al.
Publicado: (2018)

Tapentadol: an overview of the safety profile
por: Polati, Enrico, et al.
Publicado: (2019)

Tapentadol hydrochloride: A novel analgesic
por: Singh, Dewan Roshan, et al.
Publicado: (2013)

Direct conversion from tramadol to tapentadol prolonged release for moderate to severe, chronic malignant tumour‐related pain
por: Kress, H.G., et al.
Publicado: (2016)

Tapentadol: an effective option for the treatment of back pain
por: Coluzzi, Flaminia, et al.
Publicado: (2019)

Patient considerations in the use of tapentadol for moderate to severe pain
por: Vadivelu, Nalini, et al.
Publicado: (2013)

Tapentadol for neuropathic pain: a review of clinical studies
por: Freo, Ulderico, et al.
Publicado: (2019)

Tapentadol in the treatment of osteoarthritis: pharmacological rationale and clinical evidence
por: Rinonapoli, Giuseppe, et al.
Publicado: (2019)

Tapentadol extended-release for treatment of chronic pain: a review
por: Vadivelu, Nalini, et al.
Publicado: (2011)

Tapentadol extended release in the management of peripheral diabetic neuropathic pain
por: Vadivelu, Nalini, et al.
Publicado: (2015)

Tapentadol in the management of cancer pain: current evidence and future perspectives
por: Kress, Hans G, et al.
Publicado: (2019)

Pharmacological rationale for tapentadol therapy: a review of new evidence
por: Romualdi, Patrizia, et al.
Publicado: (2019)

Efficacy and safety of multiple doses of tapentadol oral solution in the treatment of moderate to severe acute pain in children aged 2 to <18 years – a randomized, double-blind, placebo-controlled trial
por: Beuter, Christoph, et al.
Publicado: (2019)

Where should analgesia lead to? Quality of life and functional recovery with tapentadol
por: Panella, Lorenzo, et al.
Publicado: (2019)

Tapentadol immediate release: a new treatment option for acute pain management
por: Afilalo, Marc, et al.
Publicado: (2010)

Tapentadol: A Review of Experimental Pharmacology Studies, Clinical Trials, and Recent Findings
por: Alshehri, Fahad S
Publicado: (2023)

A Novel Algorithm to Identify Predictors of Treatment Response: Tapentadol Monotherapy or Tapentadol/Pregabalin Combination Therapy in Chronic Low Back Pain?
por: Otto, Jan C., et al.
Publicado: (2019)

Physiologically Based Pharmacokinetic Modeling: Methodology, Applications, and Limitations with a Focus on Its Role in Pediatric Drug Development
por: Khalil, Feras, et al.
Publicado: (2011)

Prediction of response to tapentadol in chronic low back pain
por: Reimer, M., et al.
Publicado: (2016)

Tapentadol Prolonged Release: A Review in Pain Management
por: Deeks, Emma D.
Publicado: (2018)

Tapentadol: an effective option for the treatment of back pain [Corrigendum]
Publicado: (2019)

Tapentadol extended release for the management of chronic neck pain
por: Billeci, Domenico, et al.
Publicado: (2017)

Comparison of tapentadol with tramadol for analgesia after cardiac surgery
por: Iyer, Srinivas Kalyanaraman, et al.
Publicado: (2015)

Tapentadol, the new kid on the block in India: Is it time to worry?
por: Basu, Debasish, et al.
Publicado: (2020)

Trends in dispensing and utilisation of sustained-release tapentadol in Australia.
por: Camacho, Ximena, et al.
Publicado: (2022)

Tapentadol: Can It Kill Two Birds with One Stone without Breaking Windows?
por: Chang, Eun Jung, et al.
Publicado: (2016)

Analgesic Efficacy and Safety of Tapentadol Immediate Release in Bunionectomy: A Meta-Analysis
por: Franco-de la Torre, Lorenzo, et al.
Publicado: (2023)

Tapentadol Extended Release in the Treatment of Severe Chronic Low Back Pain and Osteoarthritis Pain
por: Pergolizzi, Joseph V., et al.
Publicado: (2018)

Comparison of Real-world Outcomes Between Patients Treated with Tapentadol ER or Oxycodone CR
por: Durkin, Mike, et al.
Publicado: (2015)

Comparative Efficacy of Tapentadol versus Tapentadol Plus Duloxetine in Patients with Chemotherapy-Induced Peripheral Neuropathy (CIPN): A Randomized Non-Inferiority Clinical Trial
por: Sansone, Pasquale, et al.
Publicado: (2022)

Application of Design of Experiment for Floating Drug Delivery of Tapentadol Hydrochloride
por: Jagdale, Swati C., et al.
Publicado: (2013)

Diversion and Illicit Sale of Extended Release Tapentadol in the United States
por: Dart, Richard C., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_2rnh4nba9297tpe63i2hnua3je